Bengisu Akbil

Also affiliated with Freie Universität Berlin, Charité - Universitätsmedizin Berlin

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “90K/ LGALS3BP Expression is Upregulated in COVID-19 but Does Not Restrict SARS-CoV-2 Infection”.

90K/ LGALS3BP Expression is Upregulated in COVID-19 but Does Not Restrict SARS-CoV-2 Infection

medRxiv(2022)10.1101/2022.07.18.22277255

N/A

0DataRank · unranked

0 citations

Bengisu Akbil, Johanna Leyens, Dylan Postmus, Greta Harnisch, Jenny Jansen +23 more

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection

Clinical and Experimental Medicine(2023)10.1007/s10238-023-01077-2

N/A

0DataRank · unranked

7 citations

Bengisu Akbil, Baxolele Mhlekude, Johanna Leyens, Dylan Postmus, Greta Harnisch +24 more

Synergistic latency reversal by the IAP antagonist AZD5582 and BET inhibitor JQ1, combined with Nef ablation, facilitates immune-mediated elimination of latently HIV-1-infected T-cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.06.668975

N/A

0DataRank · unranked

0 citations

CK Hui, Bengisu Akbil, Jenny Jansen, Dominic Wooding, Oya Cingöz +2 more